Company News

Share this article:

Pfizer's acquisition of Wyeth was completed today, after both companies received final regulatory approval from government officials. Wyeth will keep both of its headquarters – in Madison, NJ and Collegeville, PA – according to reports. Wyeth's shares will stop trading today, with each outstanding share converted to $33 in cash and .0985 of a Pfizer share, according to a company statement.

USA Today and analytics firm Qforma launched the second phase of their “Most Influential Doctors” partnership, with provides a doctor database (searchable by condition) to consumers via USA Today's online property. The second phase added four new conditions to the search: breast cancer, COPD, depression and osteoarthritis. Qforma created the tool using data supplied by research firm Wolters Kluwer Health.  


Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.